Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
5 Year for Various Radio Pharmaceuticals is a federal award for 250-Network Contract Office 10 (36C250) held by Guardian Pharmacy of Indianapolis Nuclear, LLC. Estimated value $350K ($350K obligated). Current period of performance ends Sep 30, 2026 (potential Sep 30, 2028). Place of performance: INDIANAPOLIS IN.
5 year for various radio pharmaceuticals. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Sep 30, 2026 (17 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on 36C25026N0072? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordGuardian Pharmacy of Indianapolis Nuclear, LLC — $1.0M obligated across 4 awards (firm-wide, all agencies).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25026N0072?
36C25026N0072 (5 year for various radio pharmaceuticals) is a 250-Network Contract Office 10 (36C250) award with a potential value of $350K, currently held by Guardian Pharmacy of Indianapolis Nuclear, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C250-26-N-0072?
36C250-26-N-0072 is the dashed form of PIID 36C25026N0072 (5 year for various radio pharmaceuticals), held by Guardian Pharmacy of Indianapolis Nuclear, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25026N0072?
250-Network Contract Office 10 (36C250) awarded 36C25026N0072 to Guardian Pharmacy of Indianapolis Nuclear, LLC (potential $350K).
Who is the incumbent on 36C25026N0072?
Guardian Pharmacy of Indianapolis Nuclear, LLC is the incumbent with $1.0M across 4 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.
When does Guardian Pharmacy of Indianapolis Nuclear, LLC’s 36C25026N0072 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C25026N0072? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.